216 related articles for article (PubMed ID: 8336397)
21. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
Nakamichi S
Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
[No Abstract] [Full Text] [Related]
22. Evaluation of latex agglutination tests for fibrin-fibrinogen degradation products in the forensic identification of menstrual blood.
Akutsu T; Watanabe K; Motani H; Iwase H; Sakurada K
Leg Med (Tokyo); 2012 Jan; 14(1):51-4. PubMed ID: 22189168
[TBL] [Abstract][Full Text] [Related]
23. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
Michielsen P; Roels L; Vanrenterghem Y; Boel A; van Damme B; Vermylen J
Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
[TBL] [Abstract][Full Text] [Related]
24. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
Song KS; Kim YA; Kim HK; Park Q
Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
[TBL] [Abstract][Full Text] [Related]
25. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
Astrug A; Shipkova P
Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
[TBL] [Abstract][Full Text] [Related]
26. Urinary fibrin (-ogen) degradation products in Russell's viper (Daboia russelii siamensis) bite victims.
Han KE; Than T; Lwin M; Swe TN; Pe T
Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):198-201. PubMed ID: 8362297
[TBL] [Abstract][Full Text] [Related]
27. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)].
Bouissou F; Barthe P; Boneu B
Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695
[TBL] [Abstract][Full Text] [Related]
28. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
[TBL] [Abstract][Full Text] [Related]
29. Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease.
Hall CL; Blainey JD; Gaffney PJ
Nephron; 1979; 23(1):6-9. PubMed ID: 450168
[TBL] [Abstract][Full Text] [Related]
30. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
Bendel M; Oetliker O; Montandon A; Beck EA
Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
[TBL] [Abstract][Full Text] [Related]
32. Urinary fibrin/fibrinogen derivatives.
Hedner U
Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
[No Abstract] [Full Text] [Related]
33. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
34. [Studies on intraglomerular coagulation in various renal diseases].
Shibata T
Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1535-47. PubMed ID: 3831470
[No Abstract] [Full Text] [Related]
35. Demonstration of reactivity to airborne and food allergens in cutaneous vasculitis by variations in fibrinopeptide A and other blood coagulation, fibrinolysis and complement parameters.
Theorell H; Blombäck M; Kockum C
Thromb Haemost; 1976 Dec; 36(3):593-604. PubMed ID: 1037153
[TBL] [Abstract][Full Text] [Related]
36. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
37. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
Sakakibara K; Nagase M; Takada Y; Takada A
Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
[TBL] [Abstract][Full Text] [Related]
38. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
[TBL] [Abstract][Full Text] [Related]
39. [Studies of urinary proteins, FDP (fibrinogen degradation products), and NAG (N-acetyl-beta-D-glucosaminidase) in renal transplanted patients].
Kunikata S; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T
Hinyokika Kiyo; 1989 Aug; 35(8):1299-304. PubMed ID: 2816597
[TBL] [Abstract][Full Text] [Related]
40. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
